A Trial of Nilvadipine in Mild to Moderate Alzheimer’s Disease (NILVAD) | C4C
To identify and potentially recruit service users who have consented to be contacted for research to be involved in CTIMP to discover whether Nilvadipine may be disease course modifying in individuals with Alzheimer’s Disease